Pages that link to "Q33737139"

The following pages link to Association of GSK3B with Alzheimer disease and frontotemporal dementia (Q33737139):

Displaying 41 items.

• Evidence for irreversible inhibition of glycogen synthase kinase-3β by tideglusib (Q24610904) (← links)
• GSK3B and MAPT polymorphisms are associated with grey matter and intracranial volume in healthy individuals (Q28535250) (← links)
• Biana: a software framework for compiling biological interactions and analyzing networks (Q33526856) (← links)
• Genome-wide network-based pathway analysis of CSF t-tau/Aβ1-42 ratio in the ADNI cohort (Q33743209) (← links)
• Drug development for Alzheimer's disease: where are we now and where are we headed? (Q34166256) (← links)
• Therapy for Alzheimer's Disease: How Effective are Current Treatments? (Q34409349) (← links)
• Decision tree analysis of genetic risk for clinically heterogeneous Alzheimer's disease (Q35603951) (← links)
• NMNAT suppresses tau-induced neurodegeneration by promoting clearance of hyperphosphorylated tau oligomers in a Drosophila model of tauopathy (Q35747174) (← links)
• Genomics of Dementia: APOE- and CYP2D6-Related Pharmacogenetics (Q35852564) (← links)
• Candidate gene resequencing to identify rare, pedigree-specific variants influencing healthy aging phenotypes in the long life family study (Q35984424) (← links)
• Glycogen synthase kinase 3: a point of integration in Alzheimer's disease and a therapeutic target? (Q36063447) (← links)
• Genetic interactions associated with 12-month atrophy in hippocampus and entorhinal cortex in Alzheimer's Disease Neuroimaging Initiative (Q36605427) (← links)
• Linking Abeta and tau in late-onset Alzheimer's disease: a dual pathway hypothesis (Q37336139) (← links)
• Genome-Wide Analysis of a Wnt1-Regulated Transcriptional Network Implicates Neurodegenerative Pathways (Q37377851) (← links)
• Pharmacogenomics and therapeutic strategies for dementia (Q37592250) (← links)
• Emerging roles of Wnts in the adult nervous system (Q37654778) (← links)
• Genome-wide DNA methylation profiles reveal novel candidate genes associated with meat quality at different age stages in hens (Q37738174) (← links)
• Genomics and pharmacogenomics of dementia (Q37780790) (← links)
• Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease (Q37845821) (← links)
• Alzheimer’s disease: pathological mechanisms and the beneficial role of melatonin (Q37959556) (← links)
• Understanding the relationship between GSK-3 and Alzheimer's disease: a focus on how GSK-3 can modulate synaptic plasticity processes (Q38101982) (← links)
• Neurotoxic saboteurs: straws that break the hippo's (hippocampus) back drive cognitive impairment and Alzheimer's Disease (Q38118901) (← links)
• Novel disease-modifying therapeutics for the treatment of Alzheimer's disease. (Q38127470) (← links)
• Plant-based vaccines for Alzheimer's disease: an overview. (Q38176962) (← links)
• Genetics in psychiatry (Q38268606) (← links)
• GSK3β-activation is a point of convergence for HIV-1 and opiate-mediated interactive neurotoxicity (Q38917051) (← links)
• Wild type and P301L mutant Tau promote neuro-inflammation and α-Synuclein accumulation in lentiviral gene delivery models (Q39994322) (← links)
• Determination of the Best Concentration of Streptozotocin to Create a Diabetic Brain Using Histological Techniques. (Q40083148) (← links)
• Aberrant Wnt signaling pathway in medial temporal lobe structures of Alzheimer's disease (Q41438444) (← links)
• Tau Phosphorylation by GSK3 in Different Conditions (Q42180899) (← links)
• Amyloid Beta and tau proteins as therapeutic targets for Alzheimer's disease treatment: rethinking the current strategy (Q42281747) (← links)
• GSK3 Function in the Brain during Development, Neuronal Plasticity, and Neurodegeneration (Q42748129) (← links)
• New organometallic imines of rhenium(i) as potential ligands of GSK-3β: synthesis, characterization and biological studies (Q47233654) (← links)
• GSK3β overexpression induces neuronal death and a depletion of the neurogenic niches in the dentate gyrus. (Q48153969) (← links)
• The CST3 B haplotype is associated with frontotemporal lobar degeneration. (Q48487351) (← links)
• Viral induced oxidative and inflammatory response in Alzheimer's disease pathogenesis with identification of potential drug candidates: A systematic review using systems biology approach. (Q52314490) (← links)
• Bioinformatics Based Therapeutic Effects of Sinomenium Acutum. (Q54120043) (← links)
• The association between single nucleotide polymorphisms of GSK 3β gene and sporadic Alzheimer's disease in a cohort of southern Chinese Han population. (Q54194186) (← links)
• Future Trends in the Pharmacogenomics of Brain Disorders and Dementia: Influence of APOE and CYP2D6 Variants. (Q55266735) (← links)
• Pathogenic Feed-Forward Mechanisms in Alzheimer's and Parkinson's Disease Converge on GSK-3 (Q60932964) (← links)
• Multi-Loop Model of Alzheimer Disease: An Integrated Perspective on the Wnt/GSK3β, α-Synuclein, and Type 3 Diabetes Hypotheses (Q92649463) (← links)